(Q53539241)

15 May 2018

title

Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007. (English)

1 reference

15 May 2018

1 reference

1

1 reference

15 May 2018

author name string

Dae-Yeon Kim

2

1 reference

15 May 2018

Dae-Shik Suh

3

1 reference

15 May 2018

Jong-Hyeok Kim

4

1 reference

15 May 2018

Yong-Man Kim

5

1 reference

15 May 2018

Young-Tak Kim

6

1 reference

15 May 2018

Joo-Hyun Nam

7

1 reference

15 May 2018

publication date

28 May 2008

1 reference

15 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

15 May 2018

volume

134

1 reference

15 May 2018

issue

12

1 reference

15 May 2018

page(s)

1277-1287

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s00432-008-0422-2

exact match

0 references

cites work

Ovarian preservation in stage I low-grade endometrial stromal sarcomas

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-008-0422-2

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

21 January 2018

1 reference

12 December 2020

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up

1 reference

12 December 2020

The management of patients with uterine sarcoma: a debated clinical challenge

1 reference

12 December 2020

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

1 reference

12 December 2020

Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? a retrospective study of prognostic factors of 60 patients stratified by stages

1 reference

12 December 2020

Retrospective analysis of 318 cases of uterine sarcoma

1 reference

12 December 2020

[Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure]

1 reference

12 December 2020

Prognostic factors and outcome in women with uterine sarcoma

1 reference

12 December 2020

Uterine sarcoma: a clinicopathological study of 93 cases.

1 reference

12 December 2020

[Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy]

1 reference

12 December 2020

Prognostic factors and treatment modalities in uterine sarcoma

1 reference

12 December 2020

Characteristics and management of uterine sarcoma patients treated at the Tom Baker Cancer Centre

1 reference

12 December 2020

Adjuvant chemotherapy in early stage uterine sarcomas: an open question

1 reference

12 December 2020

Prognostic features of sarcomas and mixed tumors of the endometrium

1 reference

12 December 2020

Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003).

1 reference

12 December 2020

Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan

1 reference

12 December 2020

Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study

1 reference

12 December 2020

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

12 December 2020

Uterine sarcomas: prognostic factors and treatment modalities--study on 209 patients

1 reference

12 December 2020

Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

1 reference

12 December 2020

Treatment of Uterine Sarcoma at the Royal Marsden Hospital from 1974 to 1998

1 reference

12 December 2020

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

1 reference

12 December 2020

The role of surgery and treatment trends in uterine sarcoma

1 reference

12 December 2020

Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial

1 reference

12 December 2020

On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus

1 reference

12 December 2020

A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study

1 reference

12 December 2020

Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma

1 reference

12 December 2020

Endometrial Stromal Sarcoma: Analysis of Treatment Failures and Survival

1 reference

12 December 2020

Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group)

1 reference

12 December 2020

An evaluation of routine follow-up of patients treated for endometrial carcinoma

1 reference

12 December 2020

A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas

1 reference

12 December 2020

Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments

1 reference

12 December 2020

10.1007/S00432-008-0422-2

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018